These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial. Goldstein G, Conant MA, Beall G, Grossman HA, Galpin JE, Blick G, Calabrese LH, Hirsch RL, Fisher A, Stampone P. J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Mar 01; 8(3):279-88. PubMed ID: 7859140 [Abstract] [Full Text] [Related]
5. The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex. Pedersen C, Cooper DA, Brun-Vézinet F, Doherty R, Skinhøj P, Pérol Y, Lüthy R, Leibowitch J, Habermehl KO, Varnier OE. AIDS; 1992 Aug 01; 6(8):821-5. PubMed ID: 1418778 [Abstract] [Full Text] [Related]
14. Response of serum p24 antigen and antibody to p24 antigen in patients with AIDS and AIDS-related complex treated with zidovudine. Williams IG, Gabriel G, Kelly G, Loveday C, Tedder RS, Weller IV. AIDS; 1990 Sep 01; 4(9):909-12. PubMed ID: 2123627 [Abstract] [Full Text] [Related]